The present invention discloses new and novel substituted anthracyclines having a three ring system or other DNA binding moieties. These congeners show high activity in vitro against several tumor cell lines. The invention also describes anthracycline-based DNA alkylators.

 
Web www.patentalert.com

< Sulfonamide derivatives, their production and use

< Physiologically acceptable aqueous solutions and methods for their use

> Cross-linked polysaccharide drug carrier

> Instrument for medical purposes
~ 00097